Manufacturer
17 recalls in our database name Mckesson Packaging Services as the manufacturing or recalling firm.
Of the 17 recalls from Mckesson Packaging Services we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1 (6%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
McKesson Packaging Services is recalling Diltiazem CD 180 mg capsules because stability testing showed high dissolution results.
McKesson Packaging Services is recalling Diltiazem HCl Extended-Release Capsules, 240 mg, because stability testing showed high dissolution results.
McKesson Packaging Services is recalling Diltiazem HCl Extended-Release Capsules because stability testing showed high dissolution results, failing specifications.
Mckesson Packaging Services is recalling Ranitidine Tablets 150 mg due to failed stability specifications. The recall affects 17,192 cartons distributed nationwide.
McKesson Packaging Services is recalling Megestrol Acetate Oral Suspension because stability testing found the drug was subpotent.
McKesson Packaging Services is recalling Propafenone Hydrochloride tablets due to failed moisture limits. The affected units were distributed to five states.
Mckesson Packaging Services is recalling BuPROPion HCL Tablets, 75 mg, due to out-of-specification moisture content.
McKesson Packaging Services is recalling 476 cartons of Donepezil HCl 10mg tablets because routine stability testing revealed an out-of-specification assay result.
McKesson Packaging Services is recalling 6,717 cartons of 81 mg Aspirin Chewable Tablets because foreign material was found in the bulk inventory.
Mckesson Packaging Services is recalling 181 cartons of Lansoprazole capsules due to a label mix-up where the outer packaging was mislabeled.
Mckesson Packaging Services is recalling 3,492 cartons of Xanax (Alprazolam) 0.5 mg tablets because the primary blister card labels are blank and lack product information.
McKesson Packaging Services is recalling SKY Aspirin Chewable Tablets because the outer cartons were incorrectly labeled. The recall addresses a labeling mix-up.
Mckesson Packaging Services is recalling Sandoz Alprazolam Tablets 0.25 mg due to the presence of stainless steel metal particulates.
McKesson Packaging Services is recalling Aspirin DR Enteric Coated Tablets because they failed to meet dissolution specifications at the 12-month time interval.
McKesson Packaging Services is recalling 1,557 boxes of Venlafaxine Hydrochloride Extended Release Capsules, 150 mg, due to out-of-specification dissolution results.
McKesson Packaging Services is recalling 187 cartons of bupropion Hydrochloride Extended-Release Tablets, 150 mg, because they failed USP dissolution test requirements.
McKesson Packaging Services is recalling bupropion hydrochloride extended-release tablets because they failed USP dissolution test requirements.